Solnica Bogdan
Zakład Diagnostyki, Katedra Biochemii Klinicznej, Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.
Przegl Lek. 2006;63(9):792-6.
Blood glucose is one of the most frequently ordered laboratory tests used mainly for diagnosis and monitoring of diabetes treatment. However, disturbances of glucose metabolism occur also in patients without diabetes in critical illnesses of various etiopathogenesis, including acute coronary syndrome, multi-organ injuries, sepsis, septic shock, burns or post-surgery trauma. The disturbances are caused by increased secretion of stress hormones and inflammatory cytokines resulting in insulin resistance and hyperglycemia. These changes worsen the course of the disease and prognosis. The management of critically ill patients should include the control of glycemia and maintaining it in the target range. The treatment includes intravenous insulin and glucose administration with monitoring of glycemia. Other abnormalities of glucose metabolism observed in various diseases are hypoglycemic states including neonatal hypoglycemia. Assays of blood glucose in critically ill patients treated in intensive care units should be performed using point-of-care testing (POCT) techniques. Measurements of real time glycemia provide the base for rapid achievement and maintaining glucose target values. It is particularly important when glucose concentrations decide on immediate physician's action, e.g. change in insulin dosage or compensation of hypoglycemia. POCT glucose assays are now included in critical care tests panel and glucose assays may be performed using various dedicated analyzers. This kind of test has its specificity associated with the kind of employed material and the measurement techniques adjusted to "fresh" blood as material of testing, distinguishing results of glucose POCT assays and results obtained in the laboratory. Tests are performed in the blood samples immediately after collection sample and take no longer than a few minutes. Real time glycemia control in intensive care unit patients has become an important part of present medical procedures.
血糖是最常进行的实验室检测项目之一,主要用于糖尿病的诊断和治疗监测。然而,在各种病因的危重病患者中,即使没有糖尿病也会出现糖代谢紊乱,包括急性冠状动脉综合征、多器官损伤、脓毒症、感染性休克、烧伤或术后创伤。这些紊乱是由应激激素和炎性细胞因子分泌增加导致胰岛素抵抗和高血糖引起的。这些变化会使疾病进程和预后恶化。危重病患者的管理应包括控制血糖并将其维持在目标范围内。治疗包括静脉输注胰岛素和葡萄糖,并监测血糖。在各种疾病中观察到的其他糖代谢异常包括低血糖状态,如新生儿低血糖。在重症监护病房接受治疗的危重病患者的血糖检测应采用即时检验(POCT)技术。实时血糖测量为快速达到并维持血糖目标值提供了依据。当血糖浓度决定医生的即时行动,如改变胰岛素剂量或纠正低血糖时,这一点尤为重要。POCT血糖检测现已纳入重症监护检测项目,血糖检测可使用各种专用分析仪进行。这种检测的特异性与所使用的材料种类以及针对“新鲜”血液作为检测材料调整的测量技术有关,这使得POCT血糖检测结果与实验室检测结果有所不同。检测在采集血样后立即进行,耗时不超过几分钟。重症监护病房患者的实时血糖控制已成为当前医疗程序的重要组成部分。